You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Muscle Invasive or Metastatic

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mood Alterations in Non-Muscle Invasive Bladder Cancer Treated

Recruiting
  • Non-Muscle Invasive Bladder Cancer
  • Questionnaires
  • +4 more
  • Washington, District of Columbia
    Sibley Memorial Hospital
Jan 17, 2023

BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder

Recruiting
  • Bladder Cancer
    • Little Rock, Arkansas
    • +2 more
    Aug 6, 2023

    Sensitivity of Multiparametric MRI in Differentiation Between

    Recruiting
    • Cancer, Bladder
    • multiparametric MRI on the bladder
    • diagnostic cystoscopy +/- TURBT
    • Badr, Cairo, Egypt
      Faculty of medicine, Helwan university
    Jun 26, 2022

    High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8, Stage 0is Bladder Cancer AJCC v8

    Not yet recruiting
    • High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
    • +3 more
    • PD-L1/IDO Peptide Vaccine
    • Pembrolizumab
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Apr 24, 2023

    Non-Muscle Invasive Bladder Cancer, Self Efficacy, Smoking Behaviors Trial in Istanbul (Behavioral: Motivational Interviewing

    Not yet recruiting
    • Non-Muscle Invasive Bladder Cancer
    • +4 more
    • Behavioral: Motivational Interviewing with WhatsApp video call
    • Istanbul, Turkey
      İrem Nur Ozdemir
    Jan 20, 2023

    Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER

    Recruiting
    • Urothelial Carcinoma
    • +2 more
      • Recife, Pernambuco, Brazil
      • +6 more
      Jul 11, 2023

      Predicting Post-cystectomy Outcome in Muscle Invasive Bladder

      Recruiting
      • Bladder Cancer
      • develop and validate a deep learning radiomics model based on preoperative enhanced CT image
      • Chongqing, Chongqing, China
        Department of Urology, The First Affiliated Hospital of Chongqin
      Oct 18, 2023

      Non-muscle-invasive Bladder Cancer, Non-Muscle Invasive Bladder Urothelial Carcinoma, High Risk Non-Muscle Invasive Bladder

      Not yet recruiting
      • Non-muscle-invasive Bladder Cancer
      • +2 more
      • PDD-TURBT with hexaminolevulinate (Hexvix®)
      • Power Led Saphira (TM) from KARL STORZ
      • (no location specified)
      Jul 24, 2023

      Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor, Radiotherapy Trial in Guangzhou (Toripalimab,

      Not yet recruiting
      • Muscle-Invasive Bladder Carcinoma
      • +2 more
      • Guangzhou, Guangdong, China
        Cancer Center, Sun Yat-sen University
      Aug 3, 2023

      Localized Muscle Invasive Bladder Urothelial Carcinoma, Muscle-Invasive Bladder Carcinoma Trial in Cleveland (Sacituzumab

      Not yet recruiting
      • Localized Muscle Invasive Bladder Urothelial Carcinoma
      • Muscle-Invasive Bladder Carcinoma
      • Sacituzumab govitecan
      • Adaptive Radiotherapy
      • Cleveland, Ohio
        Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
      Apr 18, 2023

      Muscle Invasive Bladder Cancer Trial in Boston (Durvalumab, Oleclumab)

      Completed
      • Muscle Invasive Bladder Cancer
      • Boston, Massachusetts
      • +1 more
      Sep 8, 2022

      Bladder Cancer Trial in Roskilde (Urine test)

      Recruiting
      • Bladder Cancer
        • Roskilde, Denmark
          Zealand University Hospital
        Oct 5, 2022

        Lung Diseases Trial in João Pessoa (Active non-invasive stimulation and inspiratory muscle training, Sham compatorator and

        Recruiting
        • Lung Diseases
        • Active non-invasive stimulation and inspiratory muscle training
        • Sham compatorator and inspiratory muscle training
        • João Pessoa, Paraiba, Brazil
          Federal University of Paraiba
        May 23, 2023

        Preferences for Japanese Muscle-invasive Urothelial Carcinoma of

        Not yet recruiting
        • Urinary Bladder Neoplasms
          • (no location specified)
          Feb 14, 2023

          High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma, Perfusion; Complications, Intraoperative Complications Trial

          Recruiting
          • High-Risk, Non-Muscle Invasive Bladder Urothelial Carcinoma
          • +2 more
          • hyperthermic intravesical perfusion
          • Zhengzhou, Henan, China
            BR-PRG
          Sep 15, 2022

          ctDNA in Muscle-invasive Bladder Cancer Treated With Trimodality

          Recruiting
          • Bladder Cancer
          • Muscle-Invasive Bladder Carcinoma
            • Chapel Hill, North Carolina
              North Carolina Cancer Hospital (UNC)
            Jan 11, 2023

            Non-muscle-invasive Bladder Cancer Trial in Cairo (BCG, Gemcitabine)

            Recruiting
            • Non-muscle-invasive Bladder Cancer
            • Cairo, Egypt
              Mohamed Fawzy Salman
            Nov 19, 2022

            Urinary Bladder Tumors Trial run by the NCI (Durvalumab, Vicineum)

            Recruiting
            • Urinary Bladder Neoplasms
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Feb 2, 2023

            Muscle Invasive Bladder Cancer, Urothelial Carcinoma Trial in Tianjin (Tislelizumab, Nab paclitaxel)

            Active, not recruiting
            • Muscle Invasive Bladder Cancer
            • Urothelial Carcinoma
            • Tianjin, Tianjin, China
              Tianjin Medical University Second Hospital
            Nov 23, 2022

            Non-muscle-invasive Bladder Cancer Trial in Zagreb (Gemcitabine 1000 mg, Docetaxel 37.5g)

            Active, not recruiting
            • Non-muscle-invasive Bladder Cancer
            • Gemcitabine 1000 mg, Docetaxel 37.5g
            • Zagreb, Croatia
              University Hospital Centre Zagreb
            Jan 20, 2023

            Toxicity Trial in Ghent (Adjuvant EBRT)

            Completed
            • Toxicity
            • Adjuvant EBRT
            • Ghent, Belgium
              Dept of Radiotherapy, University Hospital Ghent
            Dec 23, 2022

            Muscle-Invasive Bladder Carcinoma Trial in Utrecht (Prehabilitation)

            Not yet recruiting
            • Muscle-Invasive Bladder Carcinoma
            • Prehabilitation
            • (no location specified)
            Jul 27, 2022

            Urinary Bladder Tumors Trial in San Antonio (AGEN1884, AGEN2034, Cisplatin)

            Active, not recruiting
            • Urinary Bladder Neoplasms
            • San Antonio, Texas
              Mays Cancer Center
            Mar 11, 2022

            Urinary Bladder Cancer Trial in Assiut (Carboplatin-Gemcitabine Cisplatin-Gemcitabine)

            Recruiting
            • Urinary Bladder Cancer
            • Carboplatin-Gemcitabine Cisplatin-Gemcitabine
            • Assiut, Egypt
              AssiutU
            Apr 22, 2023

            Bladder Cancer Stage II Trial in Los Angeles (MRI imaging of the pelvis/bladder, genomic analysis of tumor)

            Recruiting
            • Bladder Cancer Stage II
            • MRI imaging of the pelvis/bladder
            • genomic analysis of tumor
            • Los Angeles, California
              Cedars-Sinai Medical Center
            Sep 27, 2022